Experience with mebendazole in the treatment of inoperable hydatid disease in England
- 1 January 1982
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 76 (4) , 510-518
- https://doi.org/10.1016/0035-9203(82)90151-1
Abstract
Eleven heterogeneous patients with inoperable hydatid disease were treated with high doses of oral mebendazole, up to 200 mg/kg/day for 16 to 48 weekKeywords
This publication has 8 references indexed in Scilit:
- Bioavailability and tolerability of mebendazole in patients with inoperable hydatid diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid diseaseEuropean Journal of Clinical Pharmacology, 1982
- Alveolar Hydatid DiseaseThe American Journal of Tropical Medicine and Hygiene, 1980
- Leukopenia Associated with Mebendazole Therapy of Hydatid DiseaseThe American Journal of Tropical Medicine and Hygiene, 1980
- Effect of mebendazole againstEchinococcus granulosus andTaenia hydatigena cysts in naturally infected sheep and relevance to larval tapeworm infections in manZeitschrift Fur Parasitenkunde-Parasitology Research, 1980
- Procedures for testing the viability of human hydatid cysts following surgical removal, especially after chemotherapyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1980
- Complication of mebendazole treatment for hydatid disease.BMJ, 1979
- MEDICAL TREATMENT FOR HYDATIDSThe Medical Journal of Australia, 1978